SINGAPORE – Last June, Singapore sealed its first deal to buy Covid-19 vaccines – before any of the more than 200 vaccine candidates had even started their phase three clinical trials.
It decided not to wait for the trials, and even paid a premium on the price, in order to secure some early stock of vaccines for people here at high risk, such as healthcare workers and the elderly.
Please subscribe or log in to continue reading the full article.
Get unlimited access to all stories at $0.99/month
Latest headlines and exclusive stories In-depth analyses and award-winning multimedia content Get access to all with our no-contract promotional package at only $0.99/month for the first 3 months* Subscribe now
*Terms and conditions apply.
Join ST’s Telegram channel here and get the latest breaking news delivered to you.